Keisuke Hashimoto

Title: Keisuke Hashimoto: Innovator in Pain Management

Introduction

Keisuke Hashimoto is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pain management through his innovative research and development efforts. His work has led to the creation of a unique therapeutic agent aimed at alleviating pain.

Latest Patents

Keisuke Hashimoto holds a patent for a therapeutic and/or preventive agent comprising a 1-indansulfamide derivative for pain. This invention focuses on a method of treating pain by administering specific 1-indansulfamide compounds. The compounds include N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide, (−)-N-(7-chloro-2,2,5-trifluoro-2,3-dihydro-1H-inden-1-yl)sulfamide, N-[(1S)-2,2-difluoro-7-methyl-2,3-dihydro-1H-inden-1-yl]sulfamide, and N-[(1S)-2,2,5-trifluoro-7-methyl-2,3-dihydro-1H-inden-1-yl]sulfamide. This patent represents a significant advancement in therapeutic options for pain relief.

Career Highlights

Keisuke Hashimoto is currently associated with Eisai R&D Management Co., Ltd., where he continues to innovate in the pharmaceutical field. His dedication to research and development has positioned him as a key figure in the industry, particularly in the area of pain management.

Collaborations

Throughout his career, Keisuke has collaborated with esteemed colleagues such as Hiroyuki Higashiyama and Yuji Kazuta. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.

Conclusion

Keisuke Hashimoto's contributions to pain management through his innovative patent demonstrate his commitment to improving therapeutic options. His work continues to influence the pharmaceutical industry and offers hope for effective pain relief solutions.